PTC Therapeutics Inc (PTCT)
33.01
-0.61
(-1.81%)
USD |
NASDAQ |
May 03, 16:00
32.98
-0.03
(-0.09%)
After-Hours: 20:00
PTC Therapeutics 1 Year Total Returns (Daily): -40.43% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 03, 2024 | -40.43% |
May 02, 2024 | -38.84% |
May 01, 2024 | -38.08% |
April 30, 2024 | -41.69% |
April 29, 2024 | -41.71% |
April 26, 2024 | -45.31% |
April 25, 2024 | -50.21% |
April 24, 2024 | -52.30% |
April 23, 2024 | -53.91% |
April 22, 2024 | -52.89% |
April 19, 2024 | -52.41% |
April 18, 2024 | -53.38% |
April 17, 2024 | -51.27% |
April 16, 2024 | -48.67% |
April 15, 2024 | -47.88% |
April 12, 2024 | -44.99% |
April 11, 2024 | -43.52% |
April 10, 2024 | -44.66% |
April 09, 2024 | -43.49% |
April 08, 2024 | -44.96% |
April 05, 2024 | -43.06% |
April 04, 2024 | -41.43% |
April 03, 2024 | -38.86% |
April 02, 2024 | -41.37% |
April 01, 2024 | -40.98% |
Date | Value |
---|---|
March 28, 2024 | -35.53% |
March 27, 2024 | -35.66% |
March 26, 2024 | -36.70% |
March 25, 2024 | -34.66% |
March 22, 2024 | -37.24% |
March 21, 2024 | -37.74% |
March 20, 2024 | -39.14% |
March 19, 2024 | -35.67% |
March 18, 2024 | -38.67% |
March 15, 2024 | -36.78% |
March 14, 2024 | -38.48% |
March 13, 2024 | -33.18% |
March 12, 2024 | -28.35% |
March 11, 2024 | -30.59% |
March 08, 2024 | -35.34% |
March 07, 2024 | -34.98% |
March 06, 2024 | -32.25% |
March 05, 2024 | -32.10% |
March 04, 2024 | -32.80% |
March 01, 2024 | -29.38% |
February 29, 2024 | -35.45% |
February 28, 2024 | -35.42% |
February 27, 2024 | -32.90% |
February 26, 2024 | -35.36% |
February 23, 2024 | -37.80% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-62.38%
Minimum
Oct 17 2023
99.33%
Maximum
Feb 19 2020
2.10%
Average
3.55%
Median
Aug 27 2019
1 Year Total Returns (Daily) Benchmarks
Sarepta Therapeutics Inc | 6.56% |
Pfizer Inc | -23.89% |
Catalyst Pharmaceuticals Inc | -11.33% |
Geron Corp | 47.19% |
Perspective Therapeutics Inc | 196.0% |